Carysil Limited (BOM:524091)
1,052.40
+29.05 (2.84%)
At close: May 21, 2026
Carysil Revenue
In the fiscal year ending March 31, 2026, Carysil had annual revenue of 9.37B INR with 14.90% growth. Carysil had revenue of 2.38B in the quarter ending March 31, 2026, with 16.73% growth.
Revenue
9.37B
Revenue Growth
+14.90%
P/S Ratio
3.29
Revenue / Employee
25.46M
Employees
368
Market Cap
30.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.37B | 1.22B | 14.90% |
| Mar 31, 2025 | 8.16B | 1.32B | 19.28% |
| Mar 31, 2024 | 6.84B | 898.72M | 15.13% |
| Mar 31, 2023 | 5.94B | 1.10B | 22.73% |
| Mar 31, 2022 | 4.84B | 1.74B | 56.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Uflex | 149.41B |
| Dalmia Bharat Sugar and Industries | 36.18B |
| Insolation Energy | 17.49B |
| Grauer & Weil (India) | 11.76B |
| Gufic Biosciences | 8.97B |
| Bliss GVS Pharma | 8.68B |
| BN Agrochem | 8.26B |
| ADF Foods | 6.83B |